Nuclear insulin-like growth factor 1 receptor phosphorylates proliferating cell nuclear antigen and rescues stalled replication forks after DNA damage by Waraky, A et al.
                                                       IGF-1R regulates PCNA ubiquitination and DNA damage 
 
1 
 
Nuclear insulin-like growth factor 1 receptor phosphorylates proliferating cell nuclear 
antigen and rescues stalled replication forks after DNA damage 
 
 
Ahmed Waraky
1
, Yingbo Lin
1
, Dudi Warsito
1
, Felix Haglund
1
, Eiman Aleem
1, 2, 3, 4
, and Olle 
Larsson
*1  
 
1 
Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska institutet, 
Stockholm, Sweden.  
2
 Institute of Molecular Medicine at Phoenix Children’s Hospital,  
3 
University of Arizona College of Medicine-Phoenix, Department of Child Health, Phoenix, 
Arizona, USA.  
4 
Alexandria University, Faculty of Science, Department of Zoology, Alexandria, Egypt.  
 
*Corresponding authors: Olle Larsson, olle.larsson@ki.se 
 
Key words: IGF-1, PCNA, DNA damage, phosphorylation, post-translational modification, 
ubiquitination 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 http://www.jbc.org/cgi/doi/10.1074/jbc.M117.781492The latest version is at 
JBC Papers in Press. Published on September 18, 2017 as Manuscript M117.781492
 Copyright 2017 by The American Society for Biochemistry and Molecular Biology, Inc.
 by guest on Septem
ber 30, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
                                                       IGF-1R regulates PCNA ubiquitination and DNA damage 
 
2 
 
 
 
Abstract 
 
We have previously shown that the insulin-
like growth factor 1 receptor (IGF-1R) 
translocates to the cell nucleus, where it 
binds to enhancer-like regions and increases 
gene transcription. Further studies have 
demonstrated that nuclear IGF-1R (nIGF-
1R) physically and functionally interacts 
with some nuclear proteins, i.e. the 
lymphoid enhancer–binding factor 1 (Lef1), 
histone H3, and Brahma-related gene-1 
proteins. In the present study, we identified 
the proliferating cell nuclear antigen 
(PCNA) as a nIGF-1R–binding partner. 
PCNA is a pivotal component of the 
replication fork machinery and a main 
regulator of the DNA damage tolerance 
(DDT) pathway. We found that IGF-1R 
interacts with and phosphorylates PCNA in 
human embryonic stem cells and other cell 
lines. In vitro MS analysis of PCNA co-
incubated with the IGF-1R kinase indicated 
tyrosine residues 60, 133, and 250 in PCNA 
as IGF-1R targets, and PCNA 
phosphorylation was followed by mono- and 
polyubiquitination. Co-immunoprecipitation 
experiments suggested that these 
ubiquitination events may be mediated by 
DDT-dependent E2/E3 ligases (e.g. RAD18 
and SHPRH/HLTF). Absence of IGF-1R or 
mutation of Tyr-60, Tyr-133, or Tyr-250 in 
PCNA abrogated its ubiquitination. Unlike 
in cells expressing IGF-1R, externally 
induced DNA damage in IGF-1R–negative 
cells caused G1 cell cycle arrest and S-phase 
fork stalling. Taken together, our results 
suggest a role of IGF-1R in DDT. 
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The insulin-like growth factor 1 receptor 
(IGF-1R) is a receptor tyrosine kinase. Upon 
ligand binding, membrane-bound receptors 
activate the phosphatidylinositol 3-kinase 
(PI3K)/Akt and mitogen-activated protein 
kinase (MAPK)/Erk signaling pathways (1). 
 
We have previously shown that 
SUMOylation of IGF-1R (at Lys1025, 
Lys1100 and Lys1120) leads to increased 
transcriptional activity due to nIGF-1R 
binding to enhancer-like sequences (2). 
Mutations of the three IGF1R SUMO 
binding residues decreased nuclear 
transcriptional activity but did not affect the 
canonical signaling pathways (PI3K/Akt and 
MAPK/Erk) of the cell membrane IGF-1R. 
nIGF-1R has also been shown to associate to 
the LEF1 transcription factor and 
phosphorylate histone H3 (3,4). While 
canonical IGF-1R signaling is well 
characterized, the functional context of 
nIGF-1R is still poorly understood.  
 
In this study we sought to identify potential 
nIGF-1R binding partners. For this purpose 
we immunoprecipitated IGF-1R from human 
embryonic stem cells (hESCs) and analyzed 
receptor associated proteins by mass 
spectrometry. One of the identified proteins 
was the proliferating cell nuclear antigen 
(PCNA), a nuclear protein that assembles in 
a homo-trimetric ring structure encircling 
the DNA double helix and functions as a 
mobile sliding clamp to recruit other 
proteins (such as DNA polymerases and 
ligases) during DNA replication (5). If 
unresolved, replication fork stalling caused 
by replication stress or DNA damage agents 
could induce genomic instability. PCNA is a 
principal component in the cellular response 
to replication fork stalling, and its 
functionality is tightly regulated in this 
respect (6-8). 
 
Ubiquitination of PCNA has been shown to 
regulate various DNA damage tolerance 
(DDT) mechanisms. PCNA 
monoubiquitination induces switching to 
low-fidelity DNA polymerases which bypass 
DNA lesions (translesion synthesis, TLS). 
Polyubiquitination is believed to initiate the 
more complex template switching (TS) 
operation, wherein the intact sister strand is 
utilized to extend past the lesion (9-11). 
Mono- and polyubiquitination of PCNA are 
mediated by two distinct sets of E2 
(ubiquitin-conjugating enzyme) and E3 
(ubiquitin-protein ligase) enzymes that 
operate in a linear fashion (12). PCNA is 
first monoubiquitinated by RAD6 (E2) and 
RAD18 (E3) (13-15), followed by K63 
polyubiquitin-linkage by UBC13-MMS2 (a 
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E2 heterodimer) and HTLF or SHPRH (E3) 
(8,9,16-18) 
In this study we demonstrate that IGF-1R 
directly phosphorylates three PCNA tyrosine 
(Y
60, 133, 250
) residues. This phosphorylation 
leads to mono- and polyubiquitination. In 
addition, our results suggest that IGF-1R 
contribute to rescue of replication fork 
stalling in cells exposed to DNA damage.  
 
Results 
 
IGF-1R is expressed in cell nucleus of 
hESC 
The nuclear localization of IGF-1R varies 
between cell types. Using immunoblotting of 
IGF-1Rβ in subcellular fractionations of 
human embryonic stem cell line H1 (WA01) 
hESCs (designated hESC henceforth). IGF-
1R was found in both nuclear and membrane 
fractions of the cell line (Figure 1A). This 
was supported by immunofluorescence 
microscopy of IGF-1R, which showed clear 
fluorescence signals within the hESC 
nucleus (Figure 1B). This result was further 
supported by analysis of R+ and R- cells. 
These cell lines are igf1r knockout MEF 
cells, stably transfected with (R+) and not 
transfected with IGF1R (R-).   
 
 
 
IGF-1R associates with PCNA in the cell 
nucleus 
To investigate the role of nIGF-1R we 
sought to collect IGF-1R binding partners by 
immunoprecipitation (IP) of IGF-1R from 
hESC and identify them by liquid 
chromatography and mass spectrometry 
(LC-MS). IP of IgG served as a negative 
control. The immunoprecipitated proteins 
were eluted, separated by SDS-PAGE and 
stained with Coomassie Blue. Ten prominent 
gel bands observed in the IGF-1R sample 
but not the IgG sample were excised (Figure 
S1A). After LC-MS, multiple potential 
binding partners were identified including 
e.g. 14-3-3 proteins (previously described to 
bind IGF1-R (19)), heat-shock associated 
proteins, Elongation factor 2 (proposed 
target of IGF-1R signaling (20)), histone H4 
and PCNA (Figure S1B). We decided to 
focus on PCNA because it exhibited several 
unique peptides and high coverage (Figure 
S1B). 
 
The association of IGF-1R with PCNA was 
confirmed using IP with anti-IGF-1R and 
reciprocal IP with anti-PCNA, followed by 
immunoblotting for PCNA and IGF-1R, 
respectively (Figure 1C). Nuclear 
association was confirmed by Co-IP after 
subcellular fractionation (Figure S1C-D) and 
In situ PLA of IGF-1R and PCNA (Figure 
1D). PLA showed clear signals abundantly 
located to the cell nuclei. 
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Next, we used R+ and R- cells to support the 
association between IGF-1R and PCNA 
(Figure 1E). While R+ exhibited this 
association, R- expectedly did not. The 
percentage of cells in S-phase and the 
expression level of PCNA (control blot) 
were similar in the two cell lines (Figure 
S2A-B). As the R+ cell line is a stable 
IGF1R transfectant produced from R- cells 
in the early ’90s (21,22), we verified the 
observed IGF-1R-PCNA interaction in a 
newly transfected R- cell line (here denoted 
R-WT). R-EV represents empty vector 
control (Figure S2C). 
 
Because R+ and R- cells provide an 
excellent cell system for comparison of the 
effect of presence and absence of IGF-1R, 
they were used as lead and control cell lines 
for investigation of IGF-1R-PCNA-
dependent events. Selected findings were 
validated on other human and mouse non-
engineered cell lines, including hESC. 
 
IGF-1R directly phosphorylates PCNA on 
Y
60
, Y
133
 and Y
250 
 
IGF-1R is an established receptor tyrosine 
kinase in the cell membrane, but was 
recently shown to exert kinase activity also 
in the cell nucleus by directly 
phosphorylating histone H3Y41 (4). 
Consequently, we investigated whether 
nIGF-1R might phosphorylate PCNA. First 
we compared PCNA tyrosine 
phosphorylation status in R+ with R- cells. 
IP of PCNA followed by detection of 
phosphotyrosine showed that PCNA is 
phosphorylated only in R+, not in R- cells 
(Figure 2A, top panel), as shown by several 
bands in R+ cells between 30-60 kDa. 
Reciprocal Co-IP confirmed this finding 
(Figure 2A, bottom panel). These results 
indicate that the expression of IGF-1R is 
necessary for tyrosine phosphorylation of 
PCNA, but do not determine whether this is 
mediated through the canonical IGF-1R 
signaling or directly by the nuclear receptor.  
 
To investigate whether IGF-1R 
phosphorylates PCNA directly, an in-vitro 
kinase assay was used. As shown, 
recombinant IGF-1R kinase domain was 
able to tyrosine phosphorylate recombinant 
PCNA (Figure 2B). The presence or absence 
of ATP in the reactions was used as control. 
The specificity of IGF-1R phosphorylation 
was further confirmed by adding IGF-1R 
inhibitor (NVP-AEW541) to the reaction 
(Figure S3A). As a positive control for the 
IGF-1R kinase activity in-vitro we showed 
that it phosphorylated itself (a bona fide 
substrate) under such conditions (Figure 
3B).  
 
In order to identify the specific PCNA 
tyrosine residue(s) being phosphorylated by 
nIGF-1R, we utilized MS analysis of 
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recombinant PCNA after in-vitro 
phosphorylation by recombinant IGF-1R. 
Recombinant PCNA without IGF-1R was 
used as negative control. The result reveals 
that residues Y
60
, Y
133
 and Y
250 
were 
phosphorylated by the IGF-1R kinase 
(Figure 2C). These data indicate that IGF-1R 
is capable of directly phosphorylating 
PCNA, suggesting that PCNA is a substrate 
of the nuclear IGF-1R tyrosine kinase 
activity. To confirm these results, the 
potential function of the Y
60
, Y
133
 and Y
250
 
residues will be considered below. 
 
IGF-1R activity does not affect PCNA 
stability 
Nuclear epidermal growth factor receptor 
(EGFR) has previously been reported to 
control PCNA stability through Y
211
 
phosphorylation (23). To investigate 
whether IGF-1R mediated PCNA 
phosphorylation affected PCNA stability, 
R+ cells were treated with either IGF-1 or 
NVP-AEW541 for 3 and 24 hours. 
However, neither IGF-1R stimulation nor 
inhibition altered the PCNA levels (Figure 
2D). Additionally, R+ and R- cells showed 
similar PCNA levels. These data suggest 
that IGF-1R does not affect PCNA stability. 
 
 
 
Nuclear IGF-1R mediated 
phosphorylation marks PCNA for 
ubiquitination 
Posttranslational modification of PCNA by 
mono- and polyubiquitination has been 
shown to control various PCNA functions, 
including the DDT pathway (see 
introduction). Using co-IP experiments we 
observed mono- and polyubiquitinated 
PCNA in R+ but not in R- cells. (Figure 
3A).  
To investigate possible involvement of IGF-
1R kinase activity in ubiquitination of 
PCNA. R+ cells were treated with either 
NVP-AEW541 or IGF-1 for 3h, followed by 
immunoprecipitation of PCNA and detection 
of phosphotyrosine and ubiquitin. IGF-1 
treatment clearly increased both PCNA 
phosphorylation and ubiquitination, while 
inhibition of IGF-1R reversed/decreased 
these effects (Figure 3B).  
 
In order to confirm the nuclear function of 
IGF-1R in inducing PCNA phosphorylation 
and subsequent ubiquitination, PCNA from 
cytoplasmic and nuclear fraction of R+ cells 
was pulled down using IP. As shown in 
Figure S5A-B, PCNA only from the nuclear 
fraction was tyrosine phosphorylated and 
ubiquitinated. Further confirmation was 
achieved by using R-TSM cells; (R- 
transfected with triple-SUMO-site-mutated 
IGF1R cell line). Just recently we showed 
that R-TSM cells exhibited diminished 
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nuclear gene regulatory effects of IGF-1R 
while retaining IGF-1R kinase-dependent 
signaling (2,24). 
IGF-1R from R+ and R-TSM was pulled 
down using IP and equal amounts of it was 
subjected to in-vitro kinase assay using 
recombinant PCNA as substrate (Figure 
S4C). As shown, only IGF-1R from R-WT 
was able to phosphorylate PCNA (Figure 
S4C). Incubation with TSM IGF-1R did not 
lead to any detectable phospho-PCNA 
signal.  IP from R- was used as negative 
control. We then analyzed ubiquitination of 
PCNA in these cell lines.  Only PCNA from 
R+ cells was phosphorylated and 
ubiquitinated (Figure S4D).  Taken together, 
the results suggest that nIGF-1R-induced 
phosphorylation of PCNA is involved in its 
ubiquitination. The inability of TSM IGF-1R 
to phosphorylate PCNA is in line with 
observed decrease in  phosphorylation of 
histone H3 in Hela cells transfected with 
TSM IGF-1R (4).  
Inhibition of the MAPK/Erk and the 
PI3K/Akt pathways using the inhibitors 
U0126 and LY2942002, respectively, did 
not decrease PCNA ubiquitination as 
compared to the untreated control (Figure 
S5A-B), which supports the notion that 
PCNA ubiquitination is mediated by nuclear 
IGF-1R and not by the canonical signaling 
of membrane IGF-1R.  
 
PCNA Y
60
, Y
133
 and Y
250 
are essential for 
recruitment of DDT-dependent ligases 
and ubiquitination 
Mono- and polyubiquitination of PCNA 
byRAD6 (E2)-RAD18 (E3) and UBC13 
(E2)-SHPRH/HLTF (E3), respectively, have 
been shown to regulate PCNA function 
through the DDT pathway (9,10). Using Co-
IP experiments, we showed the association 
of UBC13 (E2) and SHPRH/HLTF (E3) 
with PCNA in R+ but not R- cells (Figure 
3C). This suggests that nIGF-1R-dependent 
PCNA polyubiquitination may be mediated 
by these ligases. Similar results were also 
obtained for the monoubiquitinRAD18 (E3) 
ligase and the main TLS polymerase DNA 
polymerase η (Figure 3C). As a control, the 
expression of ligases in whole cell lysates 
was investigated by immunoblotting.  
Essentially similar levels are detected in R+ 
and R- cells (Figure S6A). A separate 
experiment on association of SHPRH, HTLF 
and RAD18 with PCNA, and ligase 
expression in whole cell lysates, is presented 
in Figure S7A. This experiment also 
involved a random nuclear protein (i.e. p27), 
which did not Co-IP with PCNA (Figure 
S7A).  IGF-1 stimulation increased the 
binding of SHPRH/HLTF, RAD18 and 
DNA Poly η to PCNA, whereas inhibition 
with NVP-AWE541 decreased it (Figure 
S7B).  
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The importance of PCNA Y
60
, Y
113
 and Y
250
 
phosphorylation sites for IGF-1R-PCNA 
interaction and subsequent modifications 
was then investigated by site-specific 
mutations. R+ cells were transfected with 
eGFP-PCNA constructs representing either 
wild type PCNA or mutated PCNA, resulting 
in a tyrosine replaced by a phenylalanine 
(Y60F, Y133F, Y250F or triple mutated 
Y60F-Y133F-Y250F, denoted Y-Tpl). 
Exogenous PCNA was pulled down using 
Co-IP with anti-GFP. In contrast to the 
exogenous wild type PCNA, all 4 mutants 
abolished IGF-1R/interaction, PCNA-
phosphorylation and ubiquitination, as well 
as binding of SHPRH/HLTF and RAD18 
ligases (Figure 3D). This suggests that 
phosphorylation of all three tyrosine 
residues is necessary for nIGF-1R/PCNA 
interaction. Control blots of ligase 
expression in lysates of the transfected cells 
are shown in Figure S6B.  
Together with our findings that IGF-1R 
associates with PCNA in cell nuclei (Figure 
1), and has the capacity to directly 
phosphorylate PCNA (Figure 2; Figure S3), 
it appears that the nuclear-localized receptor 
serves as the kinase and thereby triggers the 
subsequent ubiquitination. 
To verify the functional role of mutated 
PCNA constructs in DNA replication, we 
investigated GFP-gated Y-Tpl in R+ cells by 
FACS analysis after BrdU/DAPI labeling. 
Upon synchronization by serum starvation, 
the cells were released and analyzed at 
different time points (0-20 h). As shown in 
Figure S8, the cells progressed from G1 to 
and through the S phase. After 20 h, many 
cells reentered the G1 phase. Similar results 
were seen for the other (single mutated) 
eGFP-PCNA transfected cell lines (data not 
shown).  
 
IGF-1R regulates PCNA ubiquitination 
after DNA damage  
Since PCNA ubiquitination has been 
coupled to the DDT pathway mainly after 
DNA damage that induce replication fork 
stalling, we next sought to explore the 
potential role of nIGF-1R mediated PCNA 
ubiquitination in response to UV treatment. 
R+ and R- cells were exposed to UV 
irradiation, 30 mJ/cm
2
, for 30 seconds, 
followed by 1h exposure-free incubation. 
PCNA in R- cells did not exhibit any 
ubiquitination in response to UV irradiation 
(Figure 4A). Conversely, the base-line 
ubiquitination of PCNA in R+ cells was 
increased substantially by UV, but was 
attenuated if NVP-AWE541 was added prior 
to the irradiation (Figure 4A). Similarly, R+ 
cells showed a strong induction of PCNA 
ubiquitination after treatment with the 
alkylating agent methyl methanesulfonate 
(MMS) (Figure S9). This effect was 
abolished by IGF-1R inhibition. Thus, DNA 
damage-induced ubiquitination of PCNA 
was dependent on IGF-1R activity. 
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IGF-1R is involved in DDT pathway 
Our next step was to investigate role of IGF-
1R in DDT pathway. One method for 
assessing the efficiency of the DDT 
pathways is to measure the speed of 
replication restart after induction of DNA 
damage. This measures the cell’s ability to 
tolerate DNA damage upon encountering 
polymerase blocking lesions. To assess the 
functional role of IGF-1R in the DDT 
pathway, we applied the DNA fiber-labeling 
method to measure replication fork 
progression after MMS-induced DNA 
damage in R+ and R- cells. Briefly, cells 
were incubated with two different 
halogenated nucleotides, chlorodeoxyuridine 
(CldU) and iododeoxyuridine (IdU), which 
are incorporated into nascent DNA at 
replication forks before and after inducing 
DNA damage by MMS as schematically 
shown in Figure 4B. The speed of DNA 
replication restart was estimated as the 
IdU/CIdU ratios of the lengths of labeled 
nascent replication tracts before (CIdU) and 
after (IdU) induction of DNA damage. MMS 
treatment delayed DNA replication by 60% 
in R+ cells, but by as much as 90% in R- 
cells (Figure 4C). Thus, R+ cells have a 
more efficient DDT pathway than R- cells.  
 
To further characterize the role of IGF-1R in 
the DDT pathway we used FACS analysis, 
after BrdU/PI labeling, to determine the 
effect of DNA damage upon cell cycle 
progression. R+ and R- cells, were 
synchronized by serum depletion, and then 
treated with MMS or DMSO (control) for 
6h. Upon serum repletion, the R+ and R- 
control cells progressed through the cell 
cycle (Figure 5A and B). Treatment with 
MMS slowed down the cell cycle 
progression only in R+ cells (Figure 5 A-B). 
No increase in percentage of cells in G1 was 
seen in R+ cells. In R- cells, MMS treatment 
substantially inhibited cell cycle progression 
by inducing G1-cell cycle arrest, decreasing 
the number of cells in S-phase, and almost 
blocking the progression of cells into the 
G2-phase (Figure 5A and B). Further 
support for this response was obtained using 
unsynchronized cells. R+ and R- cells were 
pulse-labeled with BrdU for 1h, followed by 
treatment with DMSO or MMS for 6h 
(Figure 5C). The BrdU labeled cells were 
then gated (green dots), and the progression 
of the gated cells through S-phase after 
treatment was investigated. In a pattern that 
was basically similar to that in synchronized 
cells, the R+ cells were able to progress 
from G1/S phase to S/G2 phase at a slower 
rate after MMS treatment, while R- cells 
collapsed in G1/S phase, with minimal cells 
progression towards S/G2 phase.  
 
To further investigate the role of IGF-1R in 
DDT, we analyzed the connection between 
IGF-1R activity and PCNA phosphorylation 
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in cells entering S-phase. We used the same 
experimental condition as described in   
Figure 5A-B. Serum-starved R+ and R- cells 
were restimulated in 12h for maximal S-
phase synchronization (Figure S10A). We 
first investigated S-phase cells under 
spontaneous fork stalling (i.e. without DNA 
damage exposures).  After IP of PCNA, 
IGF-1R, p-Tyr and PCNA were detected 
(Figure S10B). In serum starved R+ cells 
(indicated as G1) there was a slight IGF-
1R/PCNA interaction and no PCNA 
phosphorylation. In contrast, R+ cells in S-
phase (indicated as S) showed a much 
stronger association between IGF-1R and 
PCNA as well as a clear PCNA 
phosphorylation. However, upon addition of 
NVP-AEW541, p-Tyr PCNA was almost 
deleted (Figure S10B).  No PCNA 
phosphorylation was seen in R- cells. Next, 
we investigated S-phase cells under 
condition of fork stalling collapse, as 
induced by a 6h MMS treatment (cf. Figure 
5A and B). As shown in Figure S10C, MMS 
treatment drastically increased 
phosphorylation of PCNA as compared to 
the negative controls. Simultaneous 
treatment with the IGF-1R inhibitor 
abrogated the MMS-induced response. No 
effects were observed in R- cells (Figure 
S10C).   These data support a role IGF-1R in 
DDT through phosphorylation of PCNA. 
 
 
IGF-1R/PCNA interaction and PCNA 
ubiquitination in cells with endogenous 
IGF-1R  
The cell lines SNL (a MEF cell line) and a 
Gm02808 (human fibroblasts) were 
compared with hESC and R+/R- cells. 
Similar to hESC and R+, the IGF-1R-PCNA 
complex was detected in SNL and GM02808 
(Figure 6A). They all exhibited PCNA 
phosphorylation and ubiquitination in a 
pattern similar to R+, but at varying levels 
(Figure 6B). And similar results were also 
shown regarding PCNA association with 
DDT-dependent E2/E3 ligases (Figure 6C). 
The expression levels of the various E2/E3 
ligases in whole cell lysates of SNL, 
GM02808 and hESC cells are shown in 
Figure 6D. 
 
Discussion 
 
The role of nuclear-localized IGF-1R in 
normal physiology and disease is still poorly 
understood. Here we identified and 
characterized a novel potential role of nIGF-
1R. We found that IGF-1R interacts with 
and phosphorylates PCNA on three tyrosine 
residues (Y
60
, Y
133
 and Y
250
), which was 
followed by ubiquitination. We also 
provided evidence that IGF-1R increases 
tolerance to DNA damage (DDT). The 
interaction between IGF-1R and PCNA may 
play a role in this respect, as we could show 
IGF-1R-dependent increase in 
 by guest on Septem
ber 30, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
                                                       IGF-1R regulates PCNA ubiquitination and DNA damage 
 
10 
 
phosphorylation of PCNA in cells entering 
S-phase under conditions of spontaneous 
fork stalling and fork stalling collapse as 
well. Together our findings suggest a 
mechanistic link between IGF-1R/PCNA 
interaction and DDT.  
 
Our opinion that IGF-1R-dependent 
phosphorylation of PCNA is mediated by 
nIGF-1R and not through the canonical 
signaling pathways via the cell membrane 
receptor is supported by the followings 
findings; (1) IGF-1R and PCNA co-localize 
exclusively in cell nuclei; (2) IGF-1R 
phosphorylates PCNA in vitro in the absence 
of other kinases; (3) PCNA is 
phosphorylated in cells expressing WT-IGF-
1R but not in those expressing TSM-IGF-
1R; and (4) inhibition of PI3K/Akt and 
MAPK/Erk activity by specific inhibitors  
did not abrogate phosphorylation and 
ubiquitination of PCNA. 
 
Other receptor tyrosine kinases have been 
shown to translocate to the nucleus and 
phosphorylate PCNA on different sites (25). 
Nuclear EGFR was reported to 
phosphorylate PCNA on Y
211
, regulating 
PCNA stability and inhibiting DNA 
mismatch repair (26). The tyrosine kinase c-
ABL has also been shown to phosphorylate 
PCNA on Y
211
, increasing DNA synthesis 
activity (27). These results are in line with 
the notion that PCNA phosphorylation may 
regulate different functions of PCNA in 
DNA-repair and replication, and the 
discrepancies may be explained by the 
different tyrosine residues modified.  
 
The identified tyrosine phosphorylated sites 
(Y
60
, Y
133
 and Y
250
 ) have been described in 
a number of previous studies mediating 
other functions. A study of global tyrosine 
phosphorylation identified a significant 
PCNA Y
250
 phosphorylation after EGF 
stimulation in HeLa-cells (28). PCNA Y
133 
was shown to be important for PCNA 
interaction with MCM10, a key component 
of the pre-replication complex (29) . It was 
shown that PCNA is phosphorylated prior to 
binding to DNA replication sites (30), 
suggesting a possible role in replication fork 
formation. Both Y
133 
and Y
250 
have 
previously been shown to participate in p21 
interaction (31). Interestingly, our site-
directed mutagenesis revealed that Y
60
, Y
133 
and
 
Y
250
 were all crucial for IGF-1R/PCNA 
interaction and subsequent ubiquitination of 
PCNA. This points to a critical role for all 
three sites, as suggested by the location of 
Y
250
 and Y
133
 tyrosine sites, which appear to 
lie within the hydrophobic groove on the 
front side adjacent to the interdomain-
connecting loop (IDCL) where most of 
PCNA interacting proteins bind to (32) 
(Figure 7A).  
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Ubiquitination of PCNA has repeatedly been 
shown to regulate DDT. In response to 
replication fork stalling, PCNA 
polyubiquitination is thought to trigger the 
DDT pathway to avoid replication fork 
collapse (9,11). Replication fork stalling 
could result from a variety of reasons 
including; DNA damage, or defects in the 
replication machinery (33). In addition, 
recent studies have showed that nucleotide 
deprivation can induce replication fork 
stalling (33,34). Thus increased proliferation 
caused by the high expression of IGF-1R 
may induce replication fork stalling through 
nucleotide deprivation. This might explain 
the presence of PCNA ubiquitination and 
association with E2/E3 ligases of the DDT 
pathway under basal growth conditions. The 
cell lines investigated by us (hESC, MEFs 
and human fibroblast cell lines) do all show 
a substantial expression IGF-1R, even in 
absence of induced exogenous DNA 
damage. This is in line with findings of 
detected  PCNA ubiquitination in Xenopus 
extracts during unperturbed DNA replication 
(35), and in human cell lines not exposed to 
exogenous DNA damage (36). Thus, even in 
the absence of exogenous DNA damaging 
agents forks stalling occurs in a significant 
fraction of the cell division cycles (33).  
 
Our finding that IGF-1R was required for 
PCNA ubiquitination in response to DNA 
damage by UV treatment is supported by 
previous studies showing that IGF-1R 
activation is associated with increased 
radioresistance both in- vitro and in-vivo 
(37,38). However, it cannot be excluded that 
other protein kinases can phosphorylate and 
regulate DDT through ubiquitination of 
PCNA in other cell systems. In yeasts, 
which lack IGF-1R, PCNA ubiquitination by 
DDT E2/E3 ligases has been demonstrated 
(9-11). 
 
The importance of PCNA in maintaining 
genomic stability has been demonstrated in a 
number of studies. An affected family 
carried a homozygous PCNA missense 
mutation, resulting in PCNA S228I (39) 
showed a decreased ability to sustain UV 
radiation through a decreased PCNA affinity 
for DNA metabolic enzymes, with no effects 
on DNA replication. Clinically, this was 
reflected by genomic hypermutability. This 
suggests that PCNA residue S228 is 
important for DNA repair rather than 
proliferation. This is compatible with our 
finding that the Y
60
, Y
133
 and Y
250
 mutants 
affect PCNA ubiquitination only, not DNA 
replication/proliferation. 
 
Deficiencies in genes regulating the DDT 
pathway have been shown to be important 
for maintaining genomic stability. HLTF-
deficient mouse embryonic fibroblasts 
showed elevated chromosome breaks and 
fusions after MMS treatment (8). Also, 
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reduction of either SHPRH or HLTF 
expression enhanced spontaneous 
mutagenesis in human fibroblasts. 
Furthermore, mutation of the XPV gene, 
encoding DNA Pol ƞ in humans, results in a 
variant type of Xeroderma pigmentosum 
(40). Patients with this disease variant are 
hypersensitive to UV damage, with reduced 
ability to elongate nascent DNA strands 
upon UV-irradiation, and are predisposed to 
cancer (9,41-43). 
Genetic syndromes with deficiencies in 
genes regulating genomic stability are being 
increasingly recognized for their relevance 
in the aging process. The connection 
between IGF-1R signaling and longevity 
was made in genetically modified mice (44) 
and there is an ongoing discussion about the 
potential link between somatotropic axis 
signaling (GH/IGF), DNA repair and DDT 
(45,46). While multiple factors may 
influence ageing in genetically altered 
models, IGF-1R might be of some 
importance for normal ageing through 
affecting DDT. A closer investigation on 
this matter is warranted. 
 
In response to replication stress or external 
DNA damage, IGF-1R-mediates PCNA 
ubiquitination, as proposed in the model 
shown in Figure 7B.  nIGF-1R 
phosphorylates PCNA on three tyrosine 
residues (Y
60,133,250
), which in turn targets 
PCNA for mono- and poly ubiquitination, 
possibly by the DDT E2/E3 ligases. The 
phosphorylation of all three tyrosine 
residues (Y60, 133, 250) appears to be 
critical for subsequent nIGF-1R-PCNA 
interaction. IGF-1R aids in protecting the 
cells from replication fork stalling and 
therewith it may contribute to maintained 
genetic stability. The effect on DDT might 
be influenced by IGF-1R/PCNA interaction 
and associated PCNA modifications. Further 
studies are needed to explore this interaction 
closer. 
 
Experimental procedures 
Reagents 
NVP-AEW541 (IGF-1R tyrosine kinase 
inhibitor) was purchased from Cayman 
Chemical (Ann Arbor, MI, USA). Insulin-
like growth factor-1 (IGF-1), U0126 
(MEK1/2 inhibitor), dimethylsulphoxide 
(DMSO), LY2942002 (PI3K inhibitor), 
polybrene, mitomycin C and β-
mercaptoethanol were all purchased from 
Sigma-Aldrich (St. Louis, MO, USA). Basic 
fibroblast growth factor (bFGF) was bought 
from R&D systems (Minneapolis, MN, 
USA) and methyl methanesulfonate (MMS) 
from Santa Cruz Biotechnology (Santa Cruz, 
CA, USA). NVP-AEW541, U0126, 
LY2942002 and MG132 were dissolved in 
DMSO and used at a concentration of 1μM, 
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5μM, 20μM and 5µM, respectively. IGF-1 
and bFGF were dissolved in 0.1% bovine 
serum albumin (BSA) in PBS (Hyclone, 
Logan, UT) and used at a final concentration 
of 100 ng/ml and 4ng/ml, respectively. 
RPMI-1640, F-12, Dulbecco's modified 
Eagle’s medium (DMEM), collagenase and 
cell culture supplements, including fetal 
bovine serum (FBS), non-essential amino 
acids (NEAA), knockout serum replacement 
(KSR), L-glutamine, puromycin and 
blasticidin were purchased from Invitrogen 
(Paisley, UK). mTeSR™1 stem cell medium 
was from Stem Cell Technologies 
(Grenoble, France). 
 
Cell cultures 
Mitotically inactive feeder cells were 
established by treating mouse embryonic 
fibroblast feeder cells (SNL, kindly provided 
by Dr. K. Wiman, Karolinska Institutet, 
Stockholm, Sweden) with 10µg/ml 
mitomycin C and cultured in DMEM with 
10% FBS and 1% NEAA. H1 (WA01) hESC 
(WiCell Research Institute Inc., Madison, 
WI, USA) cells were maintained as 
described in (47). Briefly cells were seeded 
on inactivated SNL feeder cells in DMEM-
F12 with 20% KSR in 1 mM L-glutamine, 
10 mM NEAA, 50 mM β-mercaptoethanol, 
and 4 ng/ml bFGF. All hESCs experiments 
were conducted between passage numbers 
27 and 60. For feeder-free conditions, cells 
were passaged every 4-6 days using 
collagenase and plated on Geltrex™ matrix 
in mTeSR™1 Medium in feeder-free 
conditions as described in (47).  
The platinum-A retroviral packaging cell 
line was purchased from Cell Biolabs Inc. 
(San Diego, CA, USA). Mouse embryonic 
fibroblasts (MEF) igf1r - /- (R-) and R- cells 
overexpressing IGF1R (R+) were from Dr. 
R. Baserga (Thomas Jefferson University, 
PA, USA). The R-WT (R- with newly 
transfected WT IGF1R), R-TSM (R- 
transfected  with SUMO-mutated IGF1R) 
and R-Puro (empty vector control) were 
obtained as described elsewhere (24). All 
cell lines were cultured in DMEM with 10% 
FBS, with the exception of Gm02808 being 
cultured in DMEM/F12 with 20% FBS. 
Platinum-A cells were additionally supplied 
with 1 µg/mL puromycin and 10 µg/mL 
blasticidin.  
All cell lines were maintained at 37°C in a 
humidified atmosphere containing 5% CO2 
and checked for mycoplasma using 
MycoalertTM kit (Lonza, Basel, 
Switzerland). All human cell lines were 
short tandem repeat (STR) authenticated 
using AmpFLSTR® Identifiler® Plus kit 
(Applied Biosystems, Foster City, CA, 
USA), except for Gm02808 due to lack of 
STR reference.  
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Recombinant DNA techniques 
PCNA cDNA sequence was PCR amplified 
from pEGFP-PCNA-IRES-puro2b (Addgene 
plasmids ID:26461) and inserted into 
linearized pBabe-puro empty vector (Cell 
biolabs, San Diego, CA) in between BamH I 
and EcoR I restriction sites using In-
Fusion® Dry-Down PCR cloning kit 
(Clontech, Palo Alto, CA). The constructed 
pBabe-PCNA plasmid was expanded in 
E.coli and extracted using PureLink® 
HiPure Plasmid Filter Maxiprep kit 
(Invitrogen). Site-specific mutated PCNA 
expression plasmids were generated using 
the Quick-Change® Site-Directed 
Mutagenesis kit (Agilent Technologies, 
Santa Clara, CA) using the primers listed in 
Table S1. The successful introductions of 
specific point mutations were confirmed by 
sequencing at GATC Biotech (Konstanz, 
Germany). Expression plasmids with 
multiple point mutations were created 
through several rounds of single point 
mutagenesis.  
Stable transfections 
Platinum-A virus packaging cells were 
plated in antibiotic-free medium one day 
before and a medium change was performed 
6 h before transfection. 30 µg plasmid DNA 
was mixed with 500 µl of 250 mM CaCl2, 
and added to 500 µl of 2X BES-buffered 
saline (BBS) (Sigma-Aldrich). After 
incubation at room temperature (RT) for 30 
min, the mixture with generated DNA 
precipitate was added dropwise to the cells, 
which were incubated in a CO2 incubator at 
37°C for 16 h, followed by medium change 
and additional 24h incubation. 
 
R+ cells were seeded at low density in 6-
well plates. Medium from the transfected 
Platinum-A cells containing the packaged 
retrovirus was collected, supplemented with 
8 µg/ml polybrene, filtered through 0.45µm 
polysulfonic filters (Pall Corporation, Ann 
Arbor, MI) and added to the R+ cells for 
infection. A total of three infections were 
carried out with 24h incubation intervals. 
Transfected R+ cells were obtained by 
antibiotic selection using 2 µg/ml 
puromycin. The stable clones were 
generated at limited dilution in 96-well 
plates. 
Immunoblotting 
Cells were lysed in modified RIPA buffer 
(50 mM Tris pH 7.4, 150 mM NaCl, 1% NP-
40, 1 mM EDTA, 0.25% sodium 
deoxycholate) containing protease (Roche, 
Mannheim, Germany) and phosphatase 
(Sigma-Aldrich) inhibitors, and processed as 
described in (48). Primary antibodies used in 
this research included rabbit anti-IGF-1R 
(#3024), rabbit anti- IGF-1Rβ (#3027) and 
mouse anti-PCNA (#2586) from Cell 
Signaling Technology; mouse anti-
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phosphotyrosine (sc-7020), mouse anti-
Ubiquitin (sc-8017), and goat anti-GFP (sc-
5385) from Santa Cruz Biotechnology; 
mouse anti-UBC13 (#37-1100 from Zymed 
Laboratories South San Francisco, CA, 
USA); rabbit anti-PCNA (ab18197), rabbit 
anti-SHPRH (ab80129), rabbit anti-HLTF 
(ab155031), and rabbit anti-Pol eta 
(#ab154330) from Abcam, Cambridge, UK; 
and mouse anti-Rad18 (# WH0056852M1) 
from Sigma-Aldrich. Membranes were 
incubated with secondary anti-
rabbit/mouse/goat IgG horseradish 
peroxidase-conjugated antibodies (NA934 
and NA931 from GE Life Science and 
31402 from Pierce Biotechnology) followed 
by signal detection using enhanced 
luminescence Hyperfilm-ECL (GE Life 
Science). 
Cell fractionation 
Subcellular fractionation for 
immunoprecipitation was prepared as 
described in (49) with some modifications. 
Briefly cytoplasmic fraction was achieved 
by lyzing cells in (10 mM HEPES pH 7.4, 
10 mM KCl, 0.05% NP-40) buffer. The 
nuclear fraction was achieved by washing 
the pellet with same buffer, then lyzing in 
modified RIPA buffer.  
Fractionation of membranous, cytoplasmic 
and nuclear components for western blotting 
was done using the Qiagen Qproteome Cell 
Compartment kit (Qiagen, Hilden, 
Germany). Subcellular fractionations were 
confirmed by immunoblotting for 
membranous Calnexin (rabbit anti-Calnexin, 
#2433 from Cell signaling Technology), 
cytoplasmic GAPDH or Hsp-90 (rabbit anti-
GAPDH, sc-25778 from Santa Cruz); mouse 
anti-Hsp90 (ab13492 from Abcam, 
Cambridge, UK) or nucleic Histone H2A 
(rabbit anti- H2A, #2578 from Cell signaling 
Technology) as described above. 
 
Immunoprecipitation 
The following antibodies were crosslinked 
to magnetic Protein G Dynabeads using 
Dynabeads® antibody coupling kit #14311D 
(Invitrogen): mouse anti-IGF-1R (#556000), 
mouse anti-IgG (#555746, both from BD 
Biosciences, San Jose, CA); rabbit anti-
PCNA (ab18197 from Abcam) and rabbit 
anti-IgG (sc-66931, Santa Cruz 
Biotechnology). Non-crosslinked antibodies 
included: rabbit anti-IGF-1Rβ (#3027), 
mouse anti-PCNA (#2586, both from Cell 
signaling Technology); mouse anti-IgG 
(554126 from Becton Dickinson); rabbit 
anti-IgG (sc-6693), goat anti-GFP (sc-5385) 
and mouse anti-P-Tyr (sc-7020, all from 
Santa Cruz Biotechnology).  
 
After blocking with 0.1% BSA in PBS 
(Hyclone), 2-4 mg cell lysates were 
incubated with cross-linked antibody at 
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concentrations of 4-7 μg antibody/mg beads 
for 1h at 4°C. For non-crosslinked 
antibodies, lysates were incubated overnight 
at 4°C. The immune complexes were 
washed three times with lysis buffer and 
eluted by boiling in SDS sample buffer 
(Invitrogen). Subsequent immunoblottings 
were performed as described above.  
In-vitro kinase assay 
1 μg of N-terminal His-tagged recombinant 
IGF-1R kinase domain fusion protein 
(Millipore, Bedford, MA), or endogenous 
IGF-1R pulled down using IP, was 
incubated with 2 μg of N-terminal His-
tagged PCNA fusion protein (Invitrogen) at 
30 °C for 30 min in 30 μl of kinase buffer 
(60 mM HEPES at pH 7.9, 5 mM MgCl2, 5 
mM MnCl2, 30 μM Na3VO4 and 1.25 mM 
DTT) in the presence of 20 μM ATP (all 
from Sigma-Aldrich). Omission of either 
His-tagged PCNA fusion protein, the IGF-
1R kinase domain or ATP served as negative 
controls. The reactions were terminated by 
boiling in SDS sample buffer (Invitrogen), 
followed by separations in 10% SDS–PAGE 
and immunoblottings. 
For analysis of PCNA posttranslational 
modifications, in-vitro kinase assays of His-
tagged recombinant PCNA were carried out 
with or without the recombinant IGF-1R 
kinase domain. After SDS-PAGE separation 
and Coomassie blue staining, the bands 
corresponding to PCNA were cut out and 
compared by liquid chromatography-tandem 
mass spectrometry (LC-MS/MS) analyses as 
described below. 
Immunofluorescence 
hESCs were seeded on coverslips pre-coated 
with Geltrex, fixed in 4% buffered 
paraformaldehyde, permeabilized using 
0.1% TritonX-100 and incubated overnight 
at RT with rabbit anti-IGF-1Rβ (#3027 from 
Cell signaling Technology) or mouse anti-
IGF-1Rβ (#05-656 from Millipore). Cells 
were washed with PBS and incubated with 
goat anti-rabbit Alexa Fluor 594-conjugated 
antibody (#A11012) or goat anti-mouse 
Alexa Fluor 488-conjugated antibody 
(#A11029, both from Invitrogen) for 1h at 
RT. The coverslips were mounted using 
Vectashield mounting medium containing 
DAPI (Vector Laboratories, Burlingame, 
CA) for counterstaining purposes, and 
examined using an Axioplan 2 fluorescence 
microscope (Zeiss, Jena, Germany). 
 
In situ proximity ligation assay (PLA)  
hESCs were cultured and fixed on coverslips 
as described above. Permeabilization was 
done with 0.2% TritonX-100 for 30 min at 
RT, followed by incubation with blocking 
buffer for 30 min (5% BSA, 5% Donkey 
serum, 0.3% Triton in phosphate-buffered 
saline) and mouse anti-IGF-1Rβ (#05-656 
from Millipore) or rabbit anti-PCNA 
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(#ab18197 from Abcam) at 4°C overnight. 
Duolink in situ PLA was conducted as 
previously described (Söderberg et al., 
2006), using PLA probe anti-mouse minus 
and PLA probe anti-rabbit plus (OLINK 
Bioscience, Uppsala, Sweden). 
 
Mass spectrometry 
For hESCs cells, total cell lysates were used 
for immunoprecipitation of IGF-1R or IgG 
(negative control). Precipitates were 
separated with SDS-PAGE, and co-
precipitated protein bands were visualized 
using Coomassie Blue. Ten prominent gel 
bands were exclusively seen in the IGF-1R 
lane (Figure S1A) and excised for further 
processing. Gel pieces were cut into small 
pieces and shrunk in acetonitrile. The 
samples were reduced at 56°C using 100 
mM ammonium bicarbonate containing 10 
mM DTT for 30 min. The supernatants were 
collected. Next, the samples were incubated 
in 100 mM ammonium bicarbonate 
containing 55 mM iodoacetamide at RT for 
20 min in the dark. Then the gel pieces were 
shrunk once more and the supernatant was 
collected. Gel pieces were destained in a 1:1 
mixture of 100 mM ammonium bicarbonate 
and acetonitrile for 30 min, followed by 
shrinking and aspiration of the supernatant. 
The gel pieces were then incubated on ice 
for 2h with 13 ng/µl trypsin (sequencing 
grade modified, Pierce Biotechnology) in 10 
mM ammonium bicarbonate and 10% 
acetonitrile. Digestion was carried out at 
37°C overnight. Peptides were extracted 
using 2 volumes of 1.67% formic acid in 
67% acetonitrile at 37°C for 15 min. The 
extracts were dried in a SpeedVac and 
resuspended in 3% acetonitrile, 0.1% formic 
acid. 
LC-MS was performed using a hybrid LTQ-
Orbitrap Velos mass spectrometer (Thermo 
Scientific). For each LC-MS/MS run, the 
auto sampler (HPLC 1200 system, Agilent 
Technologies) dispensed 8 μl of solvent A, 
mixed for 10 min, and proceeded to inject 3 
μl. Samples were trapped on a C18 guard 
desalting column (Agilent Technologies) 
and separated on a 15-cm long C18 picoFrit 
column (100 μm internal diameter, 5 μm 
bead size, Nikkyo Technos, Tokyo, Japan) 
installed on the nano-electrospray ionization 
source. Solvent A was 97% water, 3% 
acetonitrile and 0.1% formic acid; solvent B 
was 5% water, 95% acetonitrile and 0.1% 
formic acid. At a constant flow of 0.4 
μl/min, the curved gradient went from 2% B 
up to 40% B in 45 min, followed by a steep 
increase to 100% B in 5 min. 
The survey scan, performed in the Orbitrap 
with 30,000 resolution (and mass range 300-
2000 m/z), was followed by data-dependent 
MS/MS (centroid mode) in two stages: first, 
the top five ions from the master scan were 
selected for collision-induced dissociation 
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(CID), using 35% normalized collision 
energy with ion trap mass spectrometry 
(ITMS) detection; then the same five ions 
underwent higher energy collision 
dissociation (HCD), using 37.5% normalized 
collision energy for iTRAQ or TMT labeled 
samples, 32.5% for label-free samples 
(7,500 resolution) with detection in the 
Orbitrap (FTMS). In addition, an ETD 
procedure was used where precursors 
underwent ETD fragmentation (instead of 
CID or HCD) provided they possessed 
sufficient charge density. Accordingly, only 
triply charged precursor ions with m/z < 
650, quadruple charged ions with m/z < 900, 
quintuple charged ions with m/z < 950, or 
precursors with higher charge states were 
selected for ETD. Precursors were isolated 
with a 2 m/z window. Automatic gain 
control (AGC) targets were 1 x 106 ions for 
MS and for MS/MS 3 x 104 (CID) and 5 x 
104 (HCD). The software Proteome 
Discoverer v.1.4, including Sequest, was 
used to search the human Uniprot database 
for protein identification, limited to a false 
discovery rate of 1%. 
Cell synchronization and cell cycle 
analysis 
Cells were plated at low density and allowed 
to grow for 24h. Then they were washed 
twice with PBS and incubated in serum-free 
medium for 24h to achieve G0/G1 
synchronization, followed by release for 12h 
in medium containing 10% serum to 
synchronize cells at G1/S-Sphase. Cells 
were then treated for 6h with 1.2 mM MMS 
or vehicle. 
The proportion of synchronized cells in S 
phase was measured by bromodeoxyuridine 
(BrdU, Sigma-Aldrich) incorporation, and 
G1 and G2 phases were measured by 
staining with propidium iodide (PI, Sigma-
Aldrich) as previously described (50). 
Briefly, cells were pulse labeled with 100 
µM BrdU for 1h before harvest. For flow 
cytometry, cells were washed with PBS, 
fixed with 70% ethanol overnight and 
stained with anti-BrdU (Becton Dickinson), 
followed by FITC anti-mouse (DAKO, 
Glostrup, Denmark). Cells were then stained 
with a propidium iodide solution (50µg/ml) 
containing RNase A (20µg/ml) for 30 min at 
RT. The samples were processed using 
FACS Calibur (Becton Dickinson) and the 
data were analyzed with the Cell Quest 
software (Becton Dickinson). 
 
DNA fiber assay 
DNA replication fork dynamics were 
investigated on single DNA molecules as 
Schwab and Niedzwiedz described in 
2011.In brief, cells were pulse labeled with 
25 μM halogenated nucleotides 
chlorodeoxyuridine (CIdU), washed and 
treated with 4.3 mM MMS to induce 
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replication fork stalling or DMSO as control, 
then incubated with 250 μM 
iododeoxyuridine (IdU, Sigma-Aldrich) for 
20 min. Harvested cells were diluted to 106 
cells/ml. Spreading and staining were 
performed as described in (51). Fluorescence 
images were captured using Axioplan 2 
fluorescence microscope (Zeiss) and 
analyzed using the Image J software. At 
least 50 unidirectional forks labeled with 
both CldU and IdU were measured for every 
condition. The elongation ratio was 
calculated by length of IdU/length of CIdU, 
quantitatively reflecting the relative changes 
in replication fork efficiency.
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Figure legends: 
 
Figure 1.  Insulin-like growth factor receptor (IGF-1R) translocates to cell nucleus and 
binds to proliferating cell nuclear antigen (PCNA) 
 (A) WA01 cells (hESC cell line), grown under feeder-free conditions, were harvested and 
subjected to cell fractionation. The obtained cytoplasm, cell membrane, and nuclear fractions 
were lysed and analysed for IGF-1Rβ expression using immunoblotting (IB). Membranes 
were reblotted to determine the purity of the fractions (GAPDH for cytoplasm, calnexin for 
cell membrane and Histone H2A for nucleus).  
(B) Presence of nIGF-1R in hESC nuclei was confirmed using indirect immunofluorescence 
(2 left panels). hESC cells were incubated with IGF-1R antibody (green), counterstained with 
DAPI (blue) to visualize nuclei. The negative control was obtained by omitting the primary 
antibody.  Two right panels show the same analysis on R+ (expressing human IGF-1R) and 
R- (IGF-1R negative) MEF cells. Scale bar, 10µM. 
 (C) hESC cells were harvested, lysed and immunoprecipitated for IGF-1R β-subunit (IGF-
1R) and detected for PCNA (left panel) or immunoprecipitated for PCNA and detected for 
IGF-1Rβ (right panel). IgG was used as negative control. 
 (D) hESC cells were analysed for subcellular localization of IGF-1R–PCNA complexes by in 
situ PLA (see Materials and methods for details). hESC Red dots indicate IGF-1R–PCNA 
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interactions. Counterstaining with DAPI (blue) visualizes cell nuclei. The negative control 
was obtained by omitting one of the primary antibodies.  Scale bar, 5µM. 
(E) R+ and R- cells were immunoprecipitated for PCNA and detected for IGF-1R and PCNA 
by immunoblotting. See also Figure S2B showing this Co-IP in comparison to expression of 
IGF-1R and PCNA in the whole cell lysates. 
Data are representative of three or more independent experiments. 
 
 
Figure 2. IGF-1R phosphorylates PCNA  
(A) R+ and R- cells, grown under basal conditions until subconfluency,were harvested, lysed 
and immunoprecipitated for PCNA and detected for phospho-tyrosine  (P-Tyr) (top panel). 
Blot was stripped and incubated with anti-PCNA. Cells were also immunoprecipitated for P-
Tyr and detected for PCNA (bottom panel).  
 (B) His-Tag recombinant PCNA was subjected to an in-vitro phosphorylation reaction using 
recombinant IGF-1R kinase in presence or absence of ATP. The reactions were terminated by 
boiling in SDS sample buffer. Separation of samples in 4-12% SDS–PAGE, followed by IB 
with a P-Tyr antibody. Reblotting was made for detection of IGF-1R kinase and His-Tag 
PCNA. As indicated, negative controls were obtained by omitting recombinant IGF-1R 
kinase, recombinant His-Tagged PCNA or ATP from the reactions. Data are representative of 
three or more independent experiments. 
(C) Diagrammatic representation of peptide coverage and PTMs in PCNA with (lower panel) 
or without (upper panel) IGF-1R kinase domain as observed by LC-MS/MS. Peptides and 
phosphorylation sites with high coverage are presented in green, those with low coverage are 
presented in yellow or pink. Y60, Y133 and Y240 are highlighted by arrows.  
(D) R+ cells were treated with 1µM NVP-AEW541 (NVP), 100ng/ml IGF-1, or vehicle for 
3h and 24h, in comparison with non-treated R- cells. Cell lysates were separated on 4-12% 
Bis-Tris SDS-PAGE and subjected to immunoblotting with a PCNA antibody. Tubulin was 
used as loading control.  
 
Figure 3. IGF-1R phosphorylation is essential for ubiquitination of PCNA 
(A) R+ and R- cells were harvested, lysed and immunoprecipitated for PCNA and detected 
for ubiquitin. Blots were stripped and incubated with anti-PCNA to confirm equal loading.  
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(B) R+ cells were treated with either1µM NVP, 100ng/ml IGF-1 or vehicle for 3h, in 
comparison with non-treated R- cells. PCNA was immunoprecipitated from cells and blotted 
for Ub. Reblotting for P-Tyr and PCNA.  
(C) R+ and R- cells were immunoprecipitated for PCNA and detected for SHPRH, HLTF, 
UBC13, RAD18 or Pol η. Blots were stripped and incubated with anti-PCNA. (R-) was used 
as negative control. See Figure S6A for expression of ligases in the whole cell lysates. 
 (D) Immunoprecipitation of green-fluorescent protein (GFP) in R+ cells transfected with wild 
type (WT) or mutated tyrosine residues (Y1-3) PCNA-GFP. Y1 = Y60F, Y2 = Y133F, Y3 = 
Y250F and Y1-2-3 = triple mutant (Y60F+Y133F+Y250F). Mock transfected R+ cells were 
used as a negative control. Membranes were immunoblotted for IGF-1R, Ub, P-Tyr, SHPRH, 
HLTF, RAD18 and PCNA. See Figure S6B for expression of ligases in the whole cell lysates. 
Data are representative of three or more independent experiments. 
 
Figure 4. IGF-1R regulates ubiquitination of PCNA and replication fork progression 
after induced DNA damage  
(A) R+ and R- cells, grown under basal conditions, were treated with 1µM NVP or vehicle for 
1h, followed by UV irradiation with 30 mJ/cm2 for 30 seconds and 1h non-treatment 
incubation. Non-irradiated cells represent negative controls (Ctr). PCNA was 
immunoprecipitated from the cell lysates and subjected to IB for detection of Ub. Blots were 
stripped and incubated with anti-PCNA to confirm equal loading.  
(B) Left panel depicts a schematic diagram of protocol used for DNA fiber assay. Cells were 
pulse-labeled with halogenated nucleotides CldU (red) and IdU (green) for 20 min each. 
Using MMS, which interferes with DNA replication during the second pulse-labeling (IdU), 
fork elongation/stalling in response to replicative stress is detected. Right panel shows stained 
appearance of fork events as detected by DNA fiber assay.  
(C) DNA fibers labeled with CIdU (red) and IdU (green), as described in schematic diagram, 
used to measure replication fork restart after treating (R+) and (R-) cells with vehicle or 
4.3mM MMS for 20min (left-panel). For details see Materials and methods. Right panel 
shows graphical presentation of replication restart speed as the ratio of the lengths of nascent 
replication tracts after inducing DNA damage labeled with IdU (green) to the length of the 
replication tract before inducing damage labeled with CIdU (red). At least 50 unidirectional 
forks labeled with both CldU and IdU were measured for each condition. Scale bar, 5 µM. 
Data represent mean ± SD of three independent experiments and considered significant (*) at 
P < 0.01, using one-way ANOVA.  
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Figure 5. IGF-1R is required for cell cycle progression after induced DNA damage 
(A) FACS analysis of (R+) and (R-) cell lines, labelled with BrdU and stained with PI after 6 
h treatment with either 1.2mM MMS or DMSO. Cells were synchronized at G1 by serum 
starvation for 24h, and then released in full medium for 12h for maximal S-phase 
synchronization before treatment. 
(B) Graphic presentation of cell cycle distributions of DMSO- and MMS-treated cells. Data 
represent mean ± SD of three independent experiments and considered significant (*) at P < 
0.01, using two-sided t-test. NS, not significant. 
(C) Unsynchronized R+ and R- cells were pulse labeled with BrdU for 1h, followed by 
washing the cells from BrdU labelling and the subsequent treatment with either MMS or 
DMSO for 6h. Cells were fixed, stained for BrdU and DAPI and processed to flow cytometry. 
The BrdU labeled cells were gated (green dots) from non-BrdU labeled cells (red dots). 
 
Figure 6. IGF-1R-PCNA interaction and associated PCNA modifications in various cell 
lines 
(A)IGF-1R-PCNA interaction in indicated cell lines (SNL, Gm02808 and hESC) was 
determined by co-immunoprecipitation. Membranes were reblotted for IGF-1R for equal 
loading. R+ and R- were used as positive and negative controls, respectively.  
(B-C) Immunoprecipitates of PCNA from SNL, Gm02808 and hESC cells were 
immunoblotted for P-Tyr, Ub and PCNA (B) and E2/E3 ligases (C). R+ and R- cells were 
used as controls.  
(D) Western blot analysis showing expression of the indicated ligases (cf. Figure 6C) in 
whole cell lysates. 
Data are representative of three or more independent experiments. 
 
Figure 7. Schematic model of suggested IGF-1R/PCNA regulation of DDT pathway. 
(A) Side and front views of the crystal structure of unmodified proliferating nuclear antigen 
(PCNA) from Homo sapiens. The PCNA monomers are shaded in lime, grey and cyan. The 
tyrosine Y
60
 is shown in violet, the Y
133
 in blue and the Y
250
 in green. The interdomain 
connecting loop (IDCL) is shown in orange.  
(B) IGF-1R/PCNA regulation of DDT. See text. 
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